Not Signed In -
Diclofenac |
Voltaren |
Clinical Trial: A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients with Acute Painful Rotator Cuff Syndrome
This study is no longer recruiting patients.
|
Purpose
Comparing the short-term efficacy of rofecoxib versus placebo. Patients receive rofecoxib or placebo or diclofenac and fill out a patient diary on daytime pain severity during daily activities, night pain severity, and acetaminophen/paracetamol intake.
| Condition | Intervention | Phase |
|---|---|---|
| Pain | Drug: MK0966; rofecoxib | Phase III |
MedlinePlus related topics: Pain
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Randomized, Double-Blind, 7-Day Study of the Efficacy and Safety of Rofecoxib Versus Placebo and Diclofenac in Patients with Acute Painful Rotator Cuff Syndrome
Further Study Details:
Study start: April 2003
Eligibility
Ages Eligible for Study: 18 Years - 59 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Males or females between the ages of 18 and 59 with acute painful rotator cuff syndrome.
Location Information
France
Laboratoires Merck Sharp & Dohme - Chibret, Paris Cedex 8, 75114, France
Study chairs or principal investigators
Medical Monitor, Study Director, Merck
More Information
Study ID Numbers: 2005_056
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00140933
Health Authority: France: Ministry of Health
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00140933
Health Authority: France: Ministry of Health
ClinicalTrials.gov processed this record on 2005-09-13
Resources
- Diclofenac (Drug Digest)
- Voltaren (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
